loader
Please Wait
Applying Filters...

Minakem Minakem

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of manufacturers, suppliers & exporters who supply chemical intermediates & fine chemicals related to Candesartan Cilexetil

    Client Email Product
    Menu

    Candesartan Cilexetil

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Forms

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass

    Skyepharma, an Expert and Agile CDMO Partner for tailor-made solutions in complex oral solids and bioproduction.

    SuanFarma is present in all origins: Natural, Chemical & Biotechnological.

    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Jiangsu Zhongbang Pharmaceutical Co, Ltd (1)

    02 Smilax Laboratories Limited (3)

    03 Zhejiang Huahai Pharmaceutical Co., Ltd. (5)

    04 Zhuhai Rundu Pharmaceutical Co.,Ltd (11)

    filter

    01 124750-51-2 (1)

    02 136285-65-9 (1)

    03 139481-41-7 (2)

    04 139481-44-0 (3)

    05 139481-58-6 (1)

    06 139481-59-7 (3)

    07 139481-72-4 (2)

    08 1397836-41-7 (1)

    09 147403-52-9 (1)

    10 147403-65-4 (1)

    11 170791-09-0 (3)

    12 57113-90-3 (1)

    filter

    01 China (17)

    02 India (3)

    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Jiangsu Zhongbang Pharmaceutical Co...

    Contact Supplier
    • Audit Compliance
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    TritylCandesartan Cilexetil

    PDF Supplier PDF
    URL Supplier Web Content
    170791-09-0
    Candesartan Cilexetil
    Jiangsu Zhongbang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Red Sun Group. Company has bee...
    Jiangsu Zhongbang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Red Sun Group. Company has been founded since 2001 and occupied 100,000m2. Company has 80 million RMB registered capital and plan to have a total investment of 200 million RMB. Company has 168 employees at present, in which there are 34 employees with Bachelor’s Degree or above, 12 employees with Master’s Degree or above, each kind of professional talents have occupied over 60% of the total employees. Company has got China GMP certificate since 2006 and currently has one GMP plant for API and one GMP plant for solid finished products. There are two production lines in API GMP plants with annual capacity of 50 tons API. There are equipment for tablets, capsules and granules in solid finished products. Company has set up qualified documentation systems according to China GMP and Europe and USA C-GMP. Company has the plan to pass COS and FDA authentication both around 2014. Company also pays serious attention on public welfare and concerns on green energy conservation and environmental protection undertaking.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Smilax Laboratories Limited

    Contact Supplier
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Methyl 3-((2'-cyanobiphenyl-4-yl) methyl)-2-ethoxy-3H-b...

    PDF Supplier PDF
    URL Supplier Web Content
    139481-44-0
    Candesartan Cilexetil
    Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufactur...
    Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufacturing Active Pharmaceutical Ingredients, API Intermediates and NDDS/Pellets for the generics market across the world. Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today. Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today.Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today. Smilax manufactures APIs and API Intermediates at its state-of-the-art manufacturing facilities located at Hyderabad, Telangana and Visakhapatnam, Andhra Pradesh, India. Supported by a highly qualified and competent technical team, and endowed with strengths in research and development, Smilax continues to expand its presence in the world of pharmaceuticals.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Smilax Laboratories Limited

    Contact Supplier
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Methyl 3-((2'-(2H-tetrazol-5- yl)biphenyl-4-yl)methyl)-...

    PDF Supplier PDF
    URL Supplier Web Content
    124750-51-2
    Candesartan Cilexetil
    Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufactur...
    Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufacturing Active Pharmaceutical Ingredients, API Intermediates and NDDS/Pellets for the generics market across the world. Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today. Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today.Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today. Smilax manufactures APIs and API Intermediates at its state-of-the-art manufacturing facilities located at Hyderabad, Telangana and Visakhapatnam, Andhra Pradesh, India. Supported by a highly qualified and competent technical team, and endowed with strengths in research and development, Smilax continues to expand its presence in the world of pharmaceuticals.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Smilax Laboratories Limited

    Contact Supplier
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    3-((2'-(2H-Tetrazol-5-yl)biphenyl-4- yl)methyl)-2-ethox...

    PDF Supplier PDF
    URL Supplier Web Content
    139481-59-7
    Candesartan Cilexetil
    Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufactur...
    Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufacturing Active Pharmaceutical Ingredients, API Intermediates and NDDS/Pellets for the generics market across the world. Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today. Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today.Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today. Smilax manufactures APIs and API Intermediates at its state-of-the-art manufacturing facilities located at Hyderabad, Telangana and Visakhapatnam, Andhra Pradesh, India. Supported by a highly qualified and competent technical team, and endowed with strengths in research and development, Smilax continues to expand its presence in the world of pharmaceuticals.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Zhejiang Huahai Pharmaceutical Co.,...

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Ethyl 2-ethoxy-1-[(2'-cyanobiphenyl-4-yl)-methyl]-1H- ...

    PDF Supplier PDF
    URL Supplier Web Content
    139481-41-7
    Candesartan Cilexetil
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was succe...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Zhejiang Huahai Pharmaceutical Co.,...

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]...

    PDF Supplier PDF
    URL Supplier Web Content
    139481-59-7
    Candesartan Cilexetil
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was succe...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Zhejiang Huahai Pharmaceutical Co.,...

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Methyl 2-ethoxy-1-[(2'-cyanobiphenyl-4-yl)-methyl]-1H-...

    PDF Supplier PDF
    URL Supplier Web Content
    139481-44-0
    Candesartan Cilexetil
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was succe...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Zhejiang Huahai Pharmaceutical Co.,...

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    2-Ethoxy-1-[[2'-(N-triphenylmethyltetrazol-5-yl)-biphen...

    PDF Supplier PDF
    URL Supplier Web Content
    139481-72-4
    Candesartan Cilexetil
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was succe...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Zhejiang Huahai Pharmaceutical Co.,...

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1-tr...

    PDF Supplier PDF
    URL Supplier Web Content
    170791-09-0
    Candesartan Cilexetil
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was succe...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Zhuhai Rundu Pharmaceutical Co.,Ltd

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag China
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Ethyl 2-[(tert-butoxycarbonyI)amino]-3-nitrobenzoate

      PDF Supplier PDF
      URL Supplier Web Content
      136285-65-9
      Candesartan Cilexetil
      Zhuhai Rundu Pharmaceutical Co., Ltd. is a modern scientific and technological pharmaceutical enterprise ...
      Zhuhai Rundu Pharmaceutical Co., Ltd. is a modern scientific and technological pharmaceutical enterprise integrating drug research and development, production, and sales. It is located in Jinwan District, Zhuhai City, Guangdong Province. It was established in 1999. On January 5, 2018, the company was listed on the Shenzhen Stock Exchange (stock abbreviation: Rundu; stock code: 002923). The company's main business is the research and development, production, and sales of chemical-pharmaceutical preparations, chemical raw materials, and pharmaceutical intermediates. field.
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content
      Post Enquiry
      POST ENQUIRY